GE HealthCare Q3 revenue +6% organic; raises low end of adjusted EPS guidance

GE HealthCare Technologies Inc.

2023-Q3 EPS reported $2.15 revenue$14,346,000,000

Revenue $4.8B, up 5% reported and 6% organic YoY; net income $375M vs $487M.
Adjusted EPS $0.99 vs standalone adjusted $0.87 (+14%); GAAP EPS $0.83 vs $1.07.
Adjusted EBIT margin 15.4% (+120 bps vs standalone 14.2%); free cash flow $570M (+$22M YoY).
Full-year adjusted EPS raised to $3.75-$3.85 (prior $3.70-$3.85); organic growth 6%-8%.
Imaging +5%, Ultrasound -1%, Patient Care Solutions +9%, Pharmaceutical Diagnostics +13%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

GE HealthCare Technologies Inc. reported third quarter ended September 30, 2023 results: revenue $4.8 billion, net income $375 million, EPS $0.83. Guidance raised.

Period: third quarter ended September 30, 2023
Revenue: $4.8 billion
Net income: $375 million
EPS: $0.83
Guidance: raised
Result: reported results

Exact text from the filing

management. We remain confident in our 2023 outlook as we continue to innovate for customers and patients.” Third Quarter 2023 Total Company Financial Performance • Revenues of $4.8 billion increased 5% reported and 6% on an Organic basis* year-over-year, driven by volume and price. • Total company book-to-bill, defined as Total orders divided by Total revenues, was

View on SEC.gov

Browse all earnings releases →

GE HealthCare Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001932393-23-000124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.